Search Results - "Poet, Torka S"

Refine Results
  1. 1

    A human life-stage physiologically based pharmacokinetic and pharmacodynamic model for chlorpyrifos: Development and validation by Smith, Jordan Ned, Hinderliter, Paul M., Timchalk, Charles, Bartels, Michael J., Poet, Torka S.

    Published in Regulatory toxicology and pharmacology (01-08-2014)
    “…•A life-stage PBPK/PD model for chlorpyrifos was developed.•Simulations predict adults will have higher chlorpyrifos levels in blood.•At doses ⩾0.6mg/kg,…”
    Get full text
    Journal Article
  2. 2

    In Vitro Age-Dependent Enzymatic Metabolism of Chlorpyrifos and Chlorpyrifos-Oxon in Human Hepatic Microsomes and Chlorpyrifos-Oxon in Plasma by NED SMITH, Jordan, TIMCHALK, Charles, BARTELS, Michael J, POET, Torka S

    Published in Drug metabolism and disposition (01-08-2011)
    “…Age-dependent chlorpyrifos (CPF) metabolism was quantified by in vitro product formation in human hepatic microsomes (ages 13 days to 75 years) and plasma…”
    Get full text
    Journal Article
  3. 3

    Development of a source-to-outcome model for dietary exposures to insecticide residues: An example using chlorpyrifos by Hinderliter, Paul M., Price, Paul S., Bartels, Michael J., Timchalk, Charles, Poet, Torka S.

    Published in Regulatory toxicology and pharmacology (01-10-2011)
    “…► Source-to-outcome model for inter-individual variation at dietary dose levels. ► Differences in physiology and variation in metabolism included at ages 3 and…”
    Get full text
    Journal Article
  4. 4

    Quantitative Risk Analysis for N-Methyl Pyrrolidone Using Physiologically Based Pharmacokinetic and Benchmark Dose Modeling by Poet, Torka S., Kirman, Chris R., Bader, Michael, van Thriel, Christoph, Gargas, Michael L., Hinderliter, Paul M.

    Published in Toxicological sciences (01-02-2010)
    “…Establishing an occupational exposure limit (OEL) for N-methyl pyrrolidone (NMP) is important due to its widespread use as a solvent. Based on studies in…”
    Get full text
    Journal Article
  5. 5

    The Effect of Plasma Lipids on the Pharmacokinetics of Chlorpyrifos and the Impact on Interpretation of Blood Biomonitoring Data by Lowe, Ezra R., Poet, Torka S., Rick, David L., Marty, M. Sue, Mattsson, Joel L., Timchalk, Charles, Bartels, Michael J.

    Published in Toxicological sciences (01-04-2009)
    “…Lipophilic molecules, like chlorpyrifos (CPF), present a special problem for interpretation of biomonitoring data because both the environmental dose of CPF…”
    Get full text
    Journal Article
  6. 6

    Physiologically Based Pharmacokinetic Modeling of 1,4-Dioxane in Rats, Mice, and Humans by Sweeney, Lisa M., Thrall, Karla D., Poet, Torka S., Corley, Richard A., Weber, Thomas J., Locey, Betty J., Clarkson, Jacquelyn, Sager, Shawn, Gargas, Michael L.

    Published in Toxicological sciences (01-01-2008)
    “…1,4-Dioxane (CAS No. 123-91-1) is used primarily as a solvent or as a solvent stabilizer. It can cause lung, liver, and kidney damage at sufficiently high…”
    Get full text
    Journal Article
  7. 7

    In vitro measurements of metabolism for application in pharmacokinetic modeling by Lipscomb, John C, Poet, Torka S

    Published in Pharmacology & therapeutics (Oxford) (01-04-2008)
    “…Human risk and exposure assessments require dosimetry information. Species-specific tissue dose response will be driven by physiological and biochemical…”
    Get full text
    Journal Article
  8. 8

    Chlorpyrifos PBPK/PD model for multiple routes of exposure by Poet, Torka S., Timchalk, Charles, Hotchkiss, Jon A., Bartels, Michael J.

    Published in Xenobiotica (01-10-2014)
    “…Abstract 1. Chlorpyrifos (CPF) is an important pesticide used to control crop insects. Human Exposures to CPF will occur primarily through oral exposure to…”
    Get full text
    Journal Article
  9. 9

    Use of a probabilistic PBPK/PD model to calculate Data Derived Extrapolation Factors for chlorpyrifos by Poet, Torka S., Timchalk, Charles, Bartels, Michael J., Smith, Jordan N., McDougal, Robin, Juberg, Daland R., Price, Paul S.

    Published in Regulatory toxicology and pharmacology (01-06-2017)
    “…A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model combined with Monte Carlo analysis of inter-individual variation was used to assess…”
    Get full text
    Journal Article
  10. 10

    An Age-Dependent Physiologically Based Pharmacokinetic/Pharmacodynamic Model for the Organophosphorus Insecticide Chlorpyrifos in the Preweanling Rat by Timchalk, Charles, Kousba, Ahmed A., Poet, Torka S.

    Published in Toxicological sciences (01-08-2007)
    “…Juvenile rats are more susceptible than adults to the acute toxicity of organophosphorus insecticides like chlorpyrifos (CPF). Age- and dose-dependent…”
    Get full text
    Journal Article
  11. 11

    Comparative chlorpyrifos pharmacokinetics via multiple routes of exposure and vehicles of administration in the adult rat by Smith, Jordan Ned, Campbell, James A, Busby-Hjerpe, Andrea L, Lee, Sookwang, Poet, Torka S, Barr, Dana B, Timchalk, Charles

    Published in Toxicology (Amsterdam) (30-06-2009)
    “…Abstract Chlorpyrifos (CPF) is a commonly used organophosphorus pesticide. A number of toxicity and mechanistic studies have been conducted in animals, where…”
    Get full text
    Journal Article
  12. 12

    Age-Related Brain Cholinesterase Inhibition Kinetics following In Vitro Incubation with Chlorpyrifos-Oxon and Diazinon-Oxon by Kousba, Ahmed A., Poet, Torka S., Timchalk, Charles

    Published in Toxicological sciences (01-01-2007)
    “…Chlorpyrifos and diazinon are two commonly used organophosphorus insecticides (OPs), and their primary mechanism of action involves the inhibition of…”
    Get full text
    Journal Article
  13. 13

    Comparative pharmacokinetics of chlorpyrifos versus its major metabolites following oral administration in the rat by Busby-Hjerpe, Andrea L, Campbell, James A, Smith, Jordan Ned, Lee, Sookwang, Poet, Torka S, Barr, Dana B, Timchalk, Charles

    Published in Toxicology (Amsterdam) (31-01-2010)
    “…Abstract Chlorpyrifos (CPF) is a commonly used diethylphosphorothionate organophosphorus (OP) insecticide. Diethylphosphate (DEP), diethylthiophosphate (DETP)…”
    Get full text
    Journal Article
  14. 14

    Application of a source-to-outcome model for the assessment of health impacts from dietary exposures to insecticide residues by Price, Paul S., Schnelle, Karl D., Cleveland, Cheryl B., Bartels, Michael J., Hinderliter, Paul M., Timchalk, Charles, Poet, Torka S.

    Published in Regulatory toxicology and pharmacology (01-10-2011)
    “…► A PBPK/PD model of chlorpyrifos is used to evaluate dietary exposure in adults and children. ► Modeling allows characterization of health outcomes without…”
    Get full text
    Journal Article
  15. 15

    Effect of in vivo nicotine exposure on chlorpyrifos pharmacokinetics and pharmacodynamics in rats by Lee, Sookwang, Poet, Torka S., Smith, Jordan N., Busby-Hjerpe, Andrea L., Timchalk, Charles

    Published in Chemico-biological interactions (30-03-2010)
    “…Routine use of tobacco products may modify physiological and metabolic functions, including drug metabolizing enzymes, which may impact the pharmacokinetics of…”
    Get full text
    Journal Article
  16. 16

    Hydroquinone PBPK model refinement and application to dermal exposure by Poet, Torka S., Carlton, Betsy D., Deyo, James A., Hinderliter, Paul M.

    Published in Food and chemical toxicology (01-11-2010)
    “…A physiologically based pharmacokinetic (PBPK) model for hydroquinone (HQ) was refined to include an expanded description of HQ-glucuronide metabolites and a…”
    Get full text
    Journal Article
  17. 17

    Skin absorption and human risk assessment by Poet, Torka S., McDougal, James N.

    Published in Chemico-Biological Interactions (20-04-2002)
    “…A common practice is to assume that percutaneous absorption does not significantly contribute to total bioavailability and therefore, absorption through other…”
    Get full text
    Book Review Journal Article
  18. 18

    DETERMINATION OF BIOKINETIC INTERACTIONS IN CHEMICAL MIXTURES USING REAL-TIME BREATH ANALYSIS AND PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING by Thrall, K D, Poet, T S

    “…Regulatory agencies are challenged to conduct risk assessments on chemical mixtures without full information on toxicological interactions that may occur at…”
    Get full text
    Journal Article
  19. 19

    In vitro glutathione conjugation of methyl iodide in rat, rabbit, and human blood and tissues by Poet, Torka S., Wu, Hong, Corley, Richard A., Thrall, Karla D.

    Published in Inhalation toxicology (01-05-2009)
    “…Methyl iodide (MeI) is an intermediate in the manufacture of some pesticides and pharmaceuticals, and is under review for US registration as a non-ozone…”
    Get full text
    Journal Article
  20. 20

    Noninvasive Biomonitoring Approaches to Determine Dosimetry and Risk Following Acute Chemical Exposure: Analysis of Lead or Organophosphate Insecticide in Saliva by Timchalk, Charles, Poet, Torka S., Kousba, Ahmed A., Campbell, James A., Lin, Yuehe

    “…There is a need to develop approaches for assessing risk associated with acute exposures to a broad range of metals and chemical agents and to rapidly…”
    Get full text
    Journal Article